{
  "compound": "CBD",
  "condition": "ARTHRITIS",
  "effect_size": "Large (Cohen's d = 1.03)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:ARTHRITIS_OBSERVATIONAL_004",
  "participants": "156 children/adolescents (ages 6-17) with JIA using CBD",
  "year": 2020,
  "notes": "Cannabidiol Use in Juvenile Idiopathic Arthritis: Pediatric Registry Study",
  "confidence": "medium",
  "abstract": "62% achieved JADAS minimal disease activity; mean score 15.2 \u2192 6.8 (55% reduction)"
}